1. Home
  2. ACIC vs AUTL Comparison

ACIC vs AUTL Comparison

Compare ACIC & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACIC
  • AUTL
  • Stock Information
  • Founded
  • ACIC 1999
  • AUTL 2014
  • Country
  • ACIC United States
  • AUTL United Kingdom
  • Employees
  • ACIC N/A
  • AUTL N/A
  • Industry
  • ACIC Property-Casualty Insurers
  • AUTL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ACIC Finance
  • AUTL Health Care
  • Exchange
  • ACIC Nasdaq
  • AUTL Nasdaq
  • Market Cap
  • ACIC 556.0M
  • AUTL 625.4M
  • IPO Year
  • ACIC N/A
  • AUTL 2018
  • Fundamental
  • Price
  • ACIC $10.77
  • AUTL $2.47
  • Analyst Decision
  • ACIC Buy
  • AUTL Strong Buy
  • Analyst Count
  • ACIC 1
  • AUTL 5
  • Target Price
  • ACIC $16.00
  • AUTL $9.32
  • AVG Volume (30 Days)
  • ACIC 236.5K
  • AUTL 1.8M
  • Earning Date
  • ACIC 08-06-2025
  • AUTL 08-07-2025
  • Dividend Yield
  • ACIC 4.60%
  • AUTL N/A
  • EPS Growth
  • ACIC 3.21
  • AUTL N/A
  • EPS
  • ACIC 1.49
  • AUTL N/A
  • Revenue
  • ACIC $302,261,000.00
  • AUTL $9,011,000.00
  • Revenue This Year
  • ACIC N/A
  • AUTL $461.76
  • Revenue Next Year
  • ACIC $37.63
  • AUTL $112.66
  • P/E Ratio
  • ACIC $7.38
  • AUTL N/A
  • Revenue Growth
  • ACIC 23.92
  • AUTL N/A
  • 52 Week Low
  • ACIC $8.82
  • AUTL $1.11
  • 52 Week High
  • ACIC $15.08
  • AUTL $5.00
  • Technical
  • Relative Strength Index (RSI)
  • ACIC 47.93
  • AUTL 69.22
  • Support Level
  • ACIC $10.64
  • AUTL $2.24
  • Resistance Level
  • ACIC $11.16
  • AUTL $2.53
  • Average True Range (ATR)
  • ACIC 0.26
  • AUTL 0.13
  • MACD
  • ACIC 0.04
  • AUTL -0.00
  • Stochastic Oscillator
  • ACIC 51.58
  • AUTL 88.55

About ACIC American Coastal Insurance Corporation

American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Share on Social Networks: